CXCL8 and ovarian carcinoma: Furthermore, interleukin-8 (IL-8) triggers the activation of STAT3 signaling, which is associated with inflammation, production of reactive oxygen species, ovarian cancer tumorigenesis and multidrug resistance [19, 20].